tiprankstipranks
Trending News
More News >

Unicycive Therapeutics initiated with a Buy at Guggenheim

Guggenheim initiated coverage of Unicycive Therapeutics (UNCY) with a Buy rating and $6 price target

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue